Leukemia Lymphoma Society – in 2009 the Inaugural Care for the Cure Lacrosse Tournament donated $8,000.00 to the Leukemia Lymphoma Society. LLS is the premier fundraising leader in providing research for blood cancers.
Caroline Gallagher Cranston Memorial Fund – Since 2010 we have donated $20,000.00 to the Caroline Gallagher Cranston Memorial Fund which provides an annual scholarship to a West Chester Henderson student with like-minded characteristics.
The Headstrong Foundation – Since 2010 we have donated $16,100.00 to the Headstrong Foundation. Headstrong is one of our closest partners, supporting blood cancer patients and families through the entire end to end process. The services that Headstrong provides through their relentless initiatives in the name of founder Nick Colellouri have aided families find comfort in their biggest time of need.
Be the Match Organization – Care for the Cure has donated $2,000.00 and many donors to the Be the Match bone marrow registry. Be The Match raises funds to break down the barriers involved with bone marrow transplants, and give patients a reason to hope. Be the Match delivers tangible relief to patient families struggling with uninsured transplant costs, help add more potential marrow donors to Be The Match Registry and invest in new research discoveries.
The B+ Foundation – 2013 was our first year donating to the B+ Foundation. The Andrew McDonough B+ Foundation honors the life of 14-year-old Andrew who battled leukemia and sepsis before leaving us on July 14, 2007. Andrew’s B+ blood type became the perfect message – Be Positive – to reflect how Andrew lived his life and how he inspires others to do the same.
The Coco Foundation – In 2012 Care for the Cure made a $5,000.00 donation to the Coco Foundation, which strives to achieve three main objectives. To help fund clinical research for pediatric cancer, to raise awareness about pediatric cancers and cancer treatment, and to provide personalized support and information for children and their families dealing with pediatric cancer.